The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Antimicrobial Susceptibility Testing market was valued at US$ 1085.5 million in 2023 and is anticipated to reach US$ 1848.8 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Susceptibility Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Susceptibility Testing.
Report Scope
The Antimicrobial Susceptibility Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antimicrobial Susceptibility Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Susceptibility Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Biomérieux
- Danaher
- BD
- Thermo Fisher
- Bio-Rad
- Hi-Media
- Merlin
- Liofilchem
- Accelerate Diagnostics
- Alifax
- Creative Diagnostics
- Merck Group
- Synbiosis
- Bioanalyse
- Zhuhai Dl Biotech
Segment by Type
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Other Susceptibility Testing
Segment by Application
- Clinical Diagnostics
- Drug Discovery and Development
- Epidemiology
- Other Applications
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antimicrobial Susceptibility Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antimicrobial Susceptibility Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibacterial Susceptibility Testing
1.2.3 Antifungal Susceptibility Testing
1.2.4 Antiparasitic Susceptibility Testing
1.2.5 Other Susceptibility Testing
1.3 Market by Application
1.3.1 Global Antimicrobial Susceptibility Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery and Development
1.3.4 Epidemiology
1.3.5 Other Applications
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antimicrobial Susceptibility Testing Market Perspective (2019-2030)
2.2 Antimicrobial Susceptibility Testing Growth Trends by Region
2.2.1 Global Antimicrobial Susceptibility Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antimicrobial Susceptibility Testing Historic Market Size by Region (2019-2024)
2.2.3 Antimicrobial Susceptibility Testing Forecasted Market Size by Region (2025-2030)
2.3 Antimicrobial Susceptibility Testing Market Dynamics
2.3.1 Antimicrobial Susceptibility Testing Industry Trends
2.3.2 Antimicrobial Susceptibility Testing Market Drivers
2.3.3 Antimicrobial Susceptibility Testing Market Challenges
2.3.4 Antimicrobial Susceptibility Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antimicrobial Susceptibility Testing Players by Revenue
3.1.1 Global Top Antimicrobial Susceptibility Testing Players by Revenue (2019-2024)
3.1.2 Global Antimicrobial Susceptibility Testing Revenue Market Share by Players (2019-2024)
3.2 Global Antimicrobial Susceptibility Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antimicrobial Susceptibility Testing Revenue
3.4 Global Antimicrobial Susceptibility Testing Market Concentration Ratio
3.4.1 Global Antimicrobial Susceptibility Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antimicrobial Susceptibility Testing Revenue in 2023
3.5 Antimicrobial Susceptibility Testing Key Players Head office and Area Served
3.6 Key Players Antimicrobial Susceptibility Testing Product Solution and Service
3.7 Date of Enter into Antimicrobial Susceptibility Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antimicrobial Susceptibility Testing Breakdown Data by Type
4.1 Global Antimicrobial Susceptibility Testing Historic Market Size by Type (2019-2024)
4.2 Global Antimicrobial Susceptibility Testing Forecasted Market Size by Type (2025-2030)
5 Antimicrobial Susceptibility Testing Breakdown Data by Application
5.1 Global Antimicrobial Susceptibility Testing Historic Market Size by Application (2019-2024)
5.2 Global Antimicrobial Susceptibility Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antimicrobial Susceptibility Testing Market Size (2019-2030)
6.2 North America Antimicrobial Susceptibility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antimicrobial Susceptibility Testing Market Size by Country (2019-2024)
6.4 North America Antimicrobial Susceptibility Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antimicrobial Susceptibility Testing Market Size (2019-2030)
7.2 Europe Antimicrobial Susceptibility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antimicrobial Susceptibility Testing Market Size by Country (2019-2024)
7.4 Europe Antimicrobial Susceptibility Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antimicrobial Susceptibility Testing Market Size (2019-2030)
8.2 Asia-Pacific Antimicrobial Susceptibility Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antimicrobial Susceptibility Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Antimicrobial Susceptibility Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antimicrobial Susceptibility Testing Market Size (2019-2030)
9.2 Latin America Antimicrobial Susceptibility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antimicrobial Susceptibility Testing Market Size by Country (2019-2024)
9.4 Latin America Antimicrobial Susceptibility Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antimicrobial Susceptibility Testing Market Size (2019-2030)
10.2 Middle East & Africa Antimicrobial Susceptibility Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antimicrobial Susceptibility Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Antimicrobial Susceptibility Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biomérieux
11.1.1 Biomérieux Company Detail
11.1.2 Biomérieux Business Overview
11.1.3 Biomérieux Antimicrobial Susceptibility Testing Introduction
11.1.4 Biomérieux Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.1.5 Biomérieux Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Antimicrobial Susceptibility Testing Introduction
11.2.4 Danaher Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD Antimicrobial Susceptibility Testing Introduction
11.3.4 BD Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.3.5 BD Recent Development
11.4 Thermo Fisher
11.4.1 Thermo Fisher Company Detail
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Antimicrobial Susceptibility Testing Introduction
11.4.4 Thermo Fisher Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.4.5 Thermo Fisher Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Antimicrobial Susceptibility Testing Introduction
11.5.4 Bio-Rad Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.5.5 Bio-Rad Recent Development
11.6 Hi-Media
11.6.1 Hi-Media Company Detail
11.6.2 Hi-Media Business Overview
11.6.3 Hi-Media Antimicrobial Susceptibility Testing Introduction
11.6.4 Hi-Media Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.6.5 Hi-Media Recent Development
11.7 Merlin
11.7.1 Merlin Company Detail
11.7.2 Merlin Business Overview
11.7.3 Merlin Antimicrobial Susceptibility Testing Introduction
11.7.4 Merlin Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.7.5 Merlin Recent Development
11.8 Liofilchem
11.8.1 Liofilchem Company Detail
11.8.2 Liofilchem Business Overview
11.8.3 Liofilchem Antimicrobial Susceptibility Testing Introduction
11.8.4 Liofilchem Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.8.5 Liofilchem Recent Development
11.9 Accelerate Diagnostics
11.9.1 Accelerate Diagnostics Company Detail
11.9.2 Accelerate Diagnostics Business Overview
11.9.3 Accelerate Diagnostics Antimicrobial Susceptibility Testing Introduction
11.9.4 Accelerate Diagnostics Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.9.5 Accelerate Diagnostics Recent Development
11.10 Alifax
11.10.1 Alifax Company Detail
11.10.2 Alifax Business Overview
11.10.3 Alifax Antimicrobial Susceptibility Testing Introduction
11.10.4 Alifax Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.10.5 Alifax Recent Development
11.11 Creative Diagnostics
11.11.1 Creative Diagnostics Company Detail
11.11.2 Creative Diagnostics Business Overview
11.11.3 Creative Diagnostics Antimicrobial Susceptibility Testing Introduction
11.11.4 Creative Diagnostics Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.11.5 Creative Diagnostics Recent Development
11.12 Merck Group
11.12.1 Merck Group Company Detail
11.12.2 Merck Group Business Overview
11.12.3 Merck Group Antimicrobial Susceptibility Testing Introduction
11.12.4 Merck Group Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.12.5 Merck Group Recent Development
11.13 Synbiosis
11.13.1 Synbiosis Company Detail
11.13.2 Synbiosis Business Overview
11.13.3 Synbiosis Antimicrobial Susceptibility Testing Introduction
11.13.4 Synbiosis Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.13.5 Synbiosis Recent Development
11.14 Bioanalyse
11.14.1 Bioanalyse Company Detail
11.14.2 Bioanalyse Business Overview
11.14.3 Bioanalyse Antimicrobial Susceptibility Testing Introduction
11.14.4 Bioanalyse Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.14.5 Bioanalyse Recent Development
11.15 Zhuhai Dl Biotech
11.15.1 Zhuhai Dl Biotech Company Detail
11.15.2 Zhuhai Dl Biotech Business Overview
11.15.3 Zhuhai Dl Biotech Antimicrobial Susceptibility Testing Introduction
11.15.4 Zhuhai Dl Biotech Revenue in Antimicrobial Susceptibility Testing Business (2019-2024)
11.15.5 Zhuhai Dl Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
